Abstract
Glucocorticoid (GC)-induced apoptosis plays a major role in the treatment of acute lymphoblastic leukemia (ALL) and related malignancies. Members of the BCL2 family of pro- and anti-apoptotic proteins are regulated by GC, but to what extent these regulations contribute to GC-induced cell death and resistance development is poorly understood. Using primary lymphoblasts from ALL children during systemic GC monotherapy and related cell lines, we have previously shown that the response of the BCL2 rheostat to GC was dominated by induction of the pro-apoptotic BH3-only molecules BMF and BCL2L11/Bim, but we also observed an unexpected significant repression of the pro-apoptotic BCL2 protein PMAIP1/Noxa. Here, we report that GC represses Noxa mRNA levels and also interferes with its protein stability in a proteasome-dependent manner. Prevention of GC-mediated Noxa repression by conditional expression of transgenic Noxa changed the kinetics of GC-induced apoptosis to resemble cell death induced by BimEL alone. Hence, GC appear to activate functionally relevant pro- as well as anti-apoptotic pathways in ALL cells. Interfering with the anti-apoptotic component of the GC response might contribute to improved therapeutic approaches and circumvention of resistance to this therapy.
Similar content being viewed by others
References
Pui CH, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. N Engl J Med 350:1535–1548. doi:10.1056/NEJMra023001
Cidlowski JA, King KL, Evans-Storms RB et al (1996) The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system. Recent Prog Horm Res 51:457–490
Ashwell JD, Lu FW, Vacchio MS (2000) Glucocorticoids in T cell development and function. Annu Rev Immunol 18:309–345. doi:10.1146/annurev.immunol.18.1.309
Viegas LR, Hoijman E, Beato M et al (2008) Mechanisms involved in tissue-specific apopotosis regulated by glucocorticoids. J Steroid Biochem Mol Biol 109:273–278. doi:10.1016/j.jsbmb.2008.03.007
Herr I, Gassler N, Friess H et al (2007) Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids. Apoptosis 12:271–291. doi:10.1007/s10495-006-0624-5
Laudet V, Gronemeyer H (2002) The nuclear receptor facts book. Academic Press, London, p 1
Schmidt S, Rainer J, Ploner C et al (2004) Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 11(Suppl 1):S45–S55. doi:10.1038/sj.cdd.4401456
Schmidt S, Rainer J, Riml S et al (2006) Identification of glucocorticoid response genes in children with acute lymphoblastic leukemia. Blood 107:2061–2069. doi:10.1182/blood-2005-07-2853
Tissing WJ, den Boer ML, Meijerink JP et al (2007) Genome-wide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells. Blood 109:3929–3935. doi:10.1182/blood-2006-11-056366
Cario G, Fetz A, Bretscher C, et al (2008) Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia. Ann Hematol 87(9):709–716
Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47–59. doi:10.1038/nrm2308
Strasser A (2005) The role of BH3-only proteins in the immune system. Nat Rev Immunol 5:189–200. doi:10.1038/nri1568
Cory S, Huang DC, Adams JM (2003) The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22:8590–8607. doi:10.1038/sj.onc.1207102
Reed JC (1998) Bcl-2 family proteins. Oncogene 17:3225–3236. doi:10.1038/sj.onc.1202591
Willis SN, Fletcher JI, Kaufmann T et al (2007) Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315:856–859. doi:10.1126/science.1133289
Willis SN, Adams JM (2005) Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17:617–625. doi:10.1016/j.ceb.2005.10.001
Labi V, Erlacher M, Kiessling S et al (2006) BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death Differ 13:1325–1338. doi:10.1038/sj.cdd.4401940
Green DR (2005) Apoptotic pathways: ten minutes to dead. Cell 121:671–674. doi:10.1016/j.cell.2005.05.019
Kim H, Rafiuddin-Shah M, Tu HC et al (2006) Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8:1348–1358. doi:10.1038/ncb1499
Ploner C, Rainer J, Niederegger H et al (2008) The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia. Leukemia 22:370–377. doi:10.1038/sj.leu.2405039
Strasser-Wozak EMC, Hattmannstorfer R, Hála M et al (1995) Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. Cancer Res 55:348–353
Helmberg A, Auphan N, Caelles C et al (1995) Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 14:452–460
Parson W, Kirchebner R, Mühlmann R et al (2005) Cancer cell line identification by short tandem repeat profiling: power and limitations. FASEB J 19:434–436
Nicoletti I, Migliorati G, Pagliacci MC et al (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271–279. doi:10.1016/0022-1759(91)90198-O
Geley S, Hartmann BL, Hattmannstorfer R et al (1997) P53-induced apoptosis in the human T-ALL cell line CCRF-CEM. Oncogene 15:2429–2437. doi:10.1038/sj.onc.1201399
Rainer J, Ploner C, Jesacher S, et al (2009) Glucocorticoid regulated microRNAs and mirtrons in acute lymphoblastic leukemia. Leukemia 23(4):746–752
Smit LA, Hallaert DY, Spijker R et al (2007) Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity. Blood 109:1660–1668. doi:10.1182/blood-2006-05-021683
Löffler M, Tonko M, Hartmann BL et al (1999) c-myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblasts. Oncogene 18:4626–4631. doi:10.1038/sj.onc.1202820
Chen L, Willis SN, Wei A et al (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17:393–403. doi:10.1016/j.molcel.2004.12.030
Czabotar PE, Lee EF, van Delft MF et al (2007) Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc Natl Acad Sci USA 104:6217–6222. doi:10.1073/pnas.0701297104
Willis SN, Chen L, Dewson G et al (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19:1294–1305. doi:10.1101/gad.1304105
Wuilleme-Toumi S, Robillard N, Gomez P et al (2005) Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival. Leukemia 19:1248–1252. doi:10.1038/sj.leu.2403784
Zhong Q, Gao W, Du F et al (2005) Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121:1085–1095. doi:10.1016/j.cell.2005.06.009
Acknowledgments
We thank Dr. M. J. Ausserlechner for providing the pQ-tetCMV-Noxa-SV40-Neo plasmid, Dr. A. Villunger for helpful discussions, B. Gschirr, A. Kofler, and C. Mantinger for technical assistance, and M. Kat Occhipinti-Bender for editing the manuscript. Supported by grants from the Austrian Science Fund (SFB-F021, P18747) and by ONCOTYROL, a COMET Center funded by the Austrian Research Promotion Agency (FFG), the Tiroler Zukunftsstiftung and the Styrian Business Promotion Agency (SFG). The Tyrolean Cancer Research Institute is supported by the “Tiroler Landeskrankenanstalten Ges.m.b.H. (TILAK)”, the “Tyrolean Cancer Aid Society”, various businesses, financial institutions and the People of Tyrol.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ploner, C., Rainer, J., Lobenwein, S. et al. Repression of the BH3-only molecule PMAIP1/Noxa impairs glucocorticoid sensitivity of acute lymphoblastic leukemia cells. Apoptosis 14, 821–828 (2009). https://doi.org/10.1007/s10495-009-0355-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-009-0355-5